{"count":217,"next":null,"previous":"https://memento.epfl.ch/api/v1/events/?format=json&limit=10&offset=200&ordering=-event__url_link","results":[{"id":71949,"title":"U.S. CDMRP – Amyotrophic Lateral Sclerosis Research Program | Research Funding","slug":"us-cdmrp-amyotrophic-lateral-sclerosis-research--4","event_url":"https://memento.epfl.ch/event/us-cdmrp-amyotrophic-lateral-sclerosis-research--4","visual_url":"https://memento.epfl.ch/image/33257/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33257/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33257/max-size.jpg","lang":"en","start_date":"2026-06-24","end_date":"2026-06-24","start_time":null,"end_time":null,"description":"<strong>Aim</strong>: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2026 <strong>Amyotrophic Lateral Sclerosis Research Program (ALSRP) </strong>Awards. Several award programs are available:\r\n<ul>\r\n\t<li>The <strong>Clinical Outcomes and Biomarkers Award </strong>supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in Amyotrophic Lateral Sclerosis (ALS). Projects can be relevant to a specific therapy, a class of therapeutics, or to a specific ALS subtype (such as a particular genetic mutation) and do not have to broadly apply to all patients. Applications must address at least one of the focus areas listed <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35925310&amp;fileType=pdf\">here</a>.</li>\r\n\t<li>The <strong>Pilot Clinical Trial Award </strong>supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or symptom management of ALS. Proposed projects may range from phase 1 to small-scale phase 2 trials. Applications must address at least one of the focus areas listed <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35927287&amp;fileType=pdf\">here</a>.</li>\r\n\t<li>The <strong>Therapeutic Development Award </strong>supports research ranging from preclinical validation of therapeutic leads through FDA IND-enabling studies. The proposed studies are expected to be empirical in nature and product driven. Applicants with limited ALS experience are strongly encouraged to include collaborators with substantial experience in the relevant ALS model systems, endpoints, and pathophysiology. Candidate therapeutics that already have been granted an IND are not appropriate for the TDA.</li>\r\n\t<li>The <strong>Therapeutic Idea Award </strong>supports new, innovative, high-risk, high-gain ideas aimed at ALS drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation.</li>\r\n</ul>\r\n<strong>Funding</strong>:      \r\n\r\n<ul>\r\n\t<li>Clinical Outcomes and Biomarkers Award: max. $1M</li>\r\n\t<li>Pilot Clinical Trial Award: max. $2.8M</li>\r\n\t<li>Therapeutic Development Award: max. $2M</li>\r\n\t<li>Therapeutic Idea Award: max. $840K</li>\r\n</ul>\r\n<sup>Note: Cost caps are <strong>total costs (direct plus indirect costs). </strong>In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding</sup><br>\r\n<br>\r\n<strong>Duration</strong>:   \r\n\r\n<ul>\r\n\t<li>Clinical Outcomes and Biomarkers Award: 3 years</li>\r\n\t<li>Pilot Clinical Trial Award: 3 years</li>\r\n\t<li>Therapeutic Development Award: 3 years</li>\r\n\t<li>Therapeutic Idea Award: 2 years</li>\r\n</ul>\r\n<strong>Eligibility: </strong>Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Independent investigators at all career levels are eligible.<br>\r\n<br>\r\n<strong>How to Apply</strong>: Pre-applications are submitted through the <a href=\"https://ebrap.org/eBRAP/public/index.htm\">eBRAP platform</a>. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.<br>\r\n<br>\r\n<strong>Pre-Application Deadline: 24 June 2026, </strong>5:00 p.m. Eastern time<br>\r\n<strong>Full Application Deadline</strong>: <strong>30 September 2026</strong>, 11:59 p.m Eastern Time<br>\r\n<br>\r\n<strong>Further information:</strong>\r\n\r\n<ul>\r\n\t<li>To find the full program announcements and to start your pre-application see <a href=\"https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=707101\">here</a></li>\r\n\t<li>A useful summary of each call can be found <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241278&amp;fileType=pdf\">here</a></li>\r\n\t<li>For questions about the eBRAP or Grants.gov platforms, contact the <a href=\"mailto:research@epfl.ch\">Research Office</a>.</li>\r\n\t<li>Grants.gov Funding Opportunity Numbers:\r\n\t<ul>\r\n\t\t<li>Clinical Outcomes and Biomarkers Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35925310&amp;fileType=pdf\">HT942526ALSRPCOBA</a></li>\r\n\t\t<li>Pilot Clinical Trial Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35927287&amp;fileType=pdf\">HT942526ALSRPPCTA</a></li>\r\n\t\t<li>Therapeutic Development Award : <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35921227&amp;fileType=pdf\">HT942526ALSRPTDA</a></li>\r\n\t\t<li>Therapeutic Idea Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35919305&amp;fileType=pdf\">HT942526ALSRPTIA</a></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>","image_description":"","creation_date":"2026-05-26T19:57:31","last_modification_date":"2026-05-26T19:57:31","link_label":"","link_url":"","canceled":"False","cancel_reason":"","place_and_room":"","url_place_and_room":"","url_online_room":"","spoken_languages":["https://memento.epfl.ch/api/v1/spoken_languages/2/?format=json"],"speaker":"","organizer":"","contact":"<a href=\"mailto:research@epfl.ch\">Research Office</a>","is_internal":"False","theme":"","vulgarization":{"id":1,"fr_label":"Tout public","en_label":"General public"},"registration":{"id":3,"fr_label":"Entrée libre","en_label":"Free"},"keywords":"","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120862/","category":{"id":16,"code":"PROP","fr_label":"Appel à proposition","en_label":"Call for proposal","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/9/?format=json","https://memento.epfl.ch/api/v1/mementos/140/?format=json"]},{"id":71950,"title":"U.S. CDMRP – Peer Reviewed Cancer Research Program | Research Funding","slug":"us-cdmrp-peer-reviewed-cancer-research-program-res","event_url":"https://memento.epfl.ch/event/us-cdmrp-peer-reviewed-cancer-research-program-res","visual_url":"https://memento.epfl.ch/image/33258/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33258/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33258/max-size.jpg","lang":"en","start_date":"2026-06-26","end_date":"2026-06-26","start_time":null,"end_time":null,"description":"<strong>Aim</strong>: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2026 <strong>Peer Reviewed Cancer Research Program (PRCRP). </strong>Several award programs are available:\r\n<ul>\r\n\t<li>The <strong>Idea Award </strong>supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research. The advancement of knowledge in cancer research, patient care, and/or treatment options in the Military Health System (MHS) is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public.</li>\r\n\t<li>The <strong>Impact Award</strong> supports mature research that will have a near-term impact on clinical cancer care in one of the Topic Areas. Applicants must consider how the research project will lead to the advancement of knowledge in cancer research, patient care and/or treatment options in the MHS.</li>\r\n\t<li>The <strong>Clinical Trial Award </strong>supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of cancer within at least one of the Topic Areas. Clinical trials proposed may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) that evaluate the effects of interventions or inform the design of more advanced trials to large-scale trials (up to phase III) to determine efficacy in relevant patient populations.</li>\r\n</ul>\r\nAll applications must specifically address at least one of the <strong>Topic Areas. </strong>The FY26 PRCRP Topic Areas are listed at the end of this announcement.<br>\r\n<br>\r\n<strong>Funding</strong>:      <br>\r\n<strong>Idea Award</strong>: max. $600K<br>\r\n<strong>Impact Award</strong>: $1.5M-$2M<br>\r\n<strong>Clinical Trial Award</strong>: max. $4.5M<br>\r\n<sup>Note: Cost caps are <strong>total costs (direct plus indirect costs). </strong>In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding</sup><br>\r\n<br>\r\n<br>\r\n<strong>Duration</strong>:     <br>\r\n<strong>Idea Award</strong>: 2 years<br>\r\n<strong>Impact Award</strong>: 3 years<br>\r\n<strong>Clinical Trial Award: </strong>4 years<br>\r\n<br>\r\n<strong>Eligibility: </strong>Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Independent investigators at all career levels are eligible.<br>\r\n<br>\r\n<strong>How to Apply</strong>: Pre-applications are submitted through the <a href=\"https://ebrap.org/eBRAP/public/index.htm\">eBRAP platform</a>. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.<br>\r\n<br>\r\n<strong>Pre-Application Deadline: 26 June 2026, </strong>5:00 p.m. Eastern time<br>\r\n<strong>Full Application Deadline</strong>: <strong>05 October 2026</strong>, 11:59 p.m Eastern Time<br>\r\n                                                           <br>\r\n<strong>Further information:</strong>\r\n\r\n<ul>\r\n\t<li>To find the full program announcements and to start your pre-application see <a href=\"https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719105\">here</a></li>\r\n\t<li>A useful summary of each call can be found <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36245281&amp;fileType=pdf\">here</a></li>\r\n\t<li>For questions about the eBRAP or Grants.gov platforms, contact the <a href=\"mailto:research@epfl.ch\">Research Office</a>.</li>\r\n\t<li>Grants.gov Funding Opportunity Numbers:\r\n\t<ul>\r\n\t\t<li>Idea Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36235224&amp;fileType=pdf\">HT942526PRCRPIA</a></li>\r\n\t\t<li>Impact Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36235237&amp;fileType=pdf\">HT942526PRCRPIPA</a></li>\r\n\t\t<li>Clinical Trial Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36235233&amp;fileType=pdf\">HT942526PRCRPCTA</a></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n<strong>FY26 </strong><strong>PRCRP Topic Areas:</strong><br>\r\nBladder cancer • Blood cancers • Brain cancer • Colorectal cancer • Endometrial cancer • Esophageal cancer • Germ cell cancers • Glioblastoma • Liver cancer • Lymphoma • Mesothelioma • Metastatic cancers • Myeloma • Neuroblastoma • Neuroendocrine Tumors • Pediatric, adolescent, and young adult cancers1 • Pediatric brain tumors • Sarcoma • Stomach cancer • Thyroid cancer<br>\r\n ","image_description":"","creation_date":"2026-05-26T20:48:08","last_modification_date":"2026-05-26T20:48:08","link_label":"","link_url":"","canceled":"False","cancel_reason":"","place_and_room":"","url_place_and_room":"","url_online_room":"","spoken_languages":["https://memento.epfl.ch/api/v1/spoken_languages/2/?format=json"],"speaker":"","organizer":"","contact":"<a href=\"mailto:research@epfl.ch\">Research Office</a>","is_internal":"False","theme":"","vulgarization":{"id":1,"fr_label":"Tout public","en_label":"General public"},"registration":{"id":3,"fr_label":"Entrée libre","en_label":"Free"},"keywords":"","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120863/","category":{"id":16,"code":"PROP","fr_label":"Appel à proposition","en_label":"Call for proposal","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/9/?format=json","https://memento.epfl.ch/api/v1/mementos/140/?format=json"]},{"id":71951,"title":"Topology of spatiotemporal trajectories","slug":"topology-of-spatiotemporal-trajectories-2","event_url":"https://memento.epfl.ch/event/topology-of-spatiotemporal-trajectories-2","visual_url":"https://memento.epfl.ch/image/33259/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33259/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33259/max-size.jpg","lang":"en","start_date":"2026-05-28","end_date":"2026-05-28","start_time":"10:00:00","end_time":"11:00:00","description":"<p>In recent years, multiparameter persistent homology (MPH) has been developed to address the limitations of traditional single-parameter persistence. While much progress has been made on the theoretical aspects of MPH, practical applications have mostly been limited to the special case of two parameters. Building on recent developments in the computation of MPH in more than two parameters, we propose and implement a new algorithm for the computation of multiparameter persistence landscapes in this setting. We apply this work to compute landscapes of three-parameter persistence modules built on spatiotemporal data arising in biology.<br>\r\n </p>","image_description":"","creation_date":"2026-05-27T07:49:48","last_modification_date":"2026-05-27T07:50:08","link_label":"","link_url":"","canceled":"False","cancel_reason":"","place_and_room":"CM 1 517","url_place_and_room":"https://plan.epfl.ch/?room==CM%201%20517","url_online_room":"","spoken_languages":["https://memento.epfl.ch/api/v1/spoken_languages/2/?format=json"],"speaker":"Kate Benjamin, University of Oxford","organizer":"Joseph Griggs","contact":"Maroussia Schaffner","is_internal":"False","theme":"","vulgarization":{"id":1,"fr_label":"Tout public","en_label":"General public"},"registration":{"id":3,"fr_label":"Entrée libre","en_label":"Free"},"keywords":"","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120865/","category":{"id":1,"code":"CONF","fr_label":"Conférences - Séminaires","en_label":"Conferences - Seminars","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/5/?format=json","https://memento.epfl.ch/api/v1/mementos/7/?format=json","https://memento.epfl.ch/api/v1/mementos/9/?format=json"]},{"id":71954,"title":"From motion to interaction: integration of elementary visual cues in zebrafish social behavior","slug":"from-motion-to-interaction-integration-of-elementa","event_url":"https://memento.epfl.ch/event/from-motion-to-interaction-integration-of-elementa","visual_url":"https://memento.epfl.ch/image/33262/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33262/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33262/max-size.jpg","lang":"en","start_date":"2026-06-08","end_date":"2026-06-08","start_time":"10:30:00","end_time":"11:30:00","description":"<p>Many species live in groups and coordinate behavior with conspecifics, but the sensory computations that allow individuals to detect, evaluate, and respond to others remain difficult to study. A major challenge is that social interactions are reciprocal: animals continuously change each other’s sensory experience, making it hard to separate stimulus, perception, internal state, and behavioral response.<br>\r\n<br>\r\nIn my lab, we use juvenile zebrafish shoaling as an experimentally accessible model for vertebrate social behavior. Using virtual reality, we previously identified self-like biological motion as a visual trigger of shoaling and traced this signal into a tecto-thalamic pathway that contributes to social attraction. We now build on this framework to ask how elementary visual cues are combined into richer social representations.<br>\r\n<br>\r\nI will discuss two examples. In one project, behavioral experiments and neural recordings suggest that zebrafish evaluate group size through an integrated visual variable that combines object number and motion, so that faster small groups can become behaviorally equivalent to slower larger groups. In another, we study social buffering: the reduction of fear-related behavior by conspecific cues. Here, social information can either transmit immediate alarm or provide persistent safety, depending on context. Whole-brain activity mapping reveals neural correlates of fear state and its suppression by social cues.<br>\r\n<br>\r\nTogether, these projects show how controlled visual stimuli, quantitative behavior, whole-brain activity mapping, and cellular-resolution imaging can reveal how animals transform simple sensory features into social decisions. More broadly, this work aims to understand how nervous systems extract meaning from the motion and presence of others — from detecting social cues to finding safety in numbers.</p>","image_description":"","creation_date":"2026-05-27T13:07:49","last_modification_date":"2026-05-27T13:07:49","link_label":"","link_url":"","canceled":"False","cancel_reason":"","place_and_room":"GA 3 21","url_place_and_room":"https://plan.epfl.ch/?room==GA%203%2021","url_online_room":"","spoken_languages":["https://memento.epfl.ch/api/v1/spoken_languages/2/?format=json"],"speaker":"Prof. Johannes Larsch &lt;johannes.larsch@unil.ch&gt; ","organizer":"Prof. Sahand Jamal Rahi &lt;sahand.rahi@epfl.ch&gt;\r\n\r\nJohanni Brea &lt;johanni.brea@epfl.ch&gt; ","contact":"Prof. Sahand Jamal Rahi &lt;sahand.rahi@epfl.ch&gt;\r\n\r\nJohanni Brea &lt;johanni.brea@epfl.ch&gt; ","is_internal":"False","theme":"","vulgarization":{"id":2,"fr_label":"Public averti","en_label":"Informed public"},"registration":{"id":1,"fr_label":"Sur inscription","en_label":"Registration required"},"keywords":"","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120869/","category":{"id":1,"code":"CONF","fr_label":"Conférences - Séminaires","en_label":"Conferences - Seminars","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/9/?format=json","https://memento.epfl.ch/api/v1/mementos/111/?format=json"]},{"id":71955,"title":"Markovian analysis of Zebrafish swimming","slug":"markovian-analysis-of-zebrafish-swimming","event_url":"https://memento.epfl.ch/event/markovian-analysis-of-zebrafish-swimming","visual_url":"https://memento.epfl.ch/image/33263/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33263/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33263/max-size.jpg","lang":"en","start_date":"2026-06-10","end_date":"2026-06-10","start_time":"14:30:00","end_time":"15:30:00","description":"<strong>Abstract :</strong><br>\r\nIn this interactive Python tutorial, we will learn how Markovian frameworks can be used to analyze and model spontaneous locomotion from behavioral time series. We will use zebrafish reorientation behavior as example.<br>\r\nStarting from discrete swim-bout sequences, we will introduce Markov chains as tools for quantifying transition structure, behavioral persistence, and temperature-dependent changes in exploratory strategies. <br>\r\nIf time allows, we will then extend this approach to Hidden Markov Models, showing how latent behavioral states can be inferred directly from continuous kinematic observations. ","image_description":"","creation_date":"2026-05-27T13:15:24","last_modification_date":"2026-05-27T13:15:24","link_label":"","link_url":"","canceled":"False","cancel_reason":"","place_and_room":"GA 3 21","url_place_and_room":"https://plan.epfl.ch/?room==GA%203%2021","url_online_room":"","spoken_languages":["https://memento.epfl.ch/api/v1/spoken_languages/2/?format=json"],"speaker":"Prof. Mattéo Dommanget-Kott &lt;matteo.dommanget-kott@sorbonne-universite.fr&gt; ","organizer":"Prof. Sahand Jamal Rahi &lt;sahand.rahi@epfl.ch&gt;\r\n\r\nJohanni Brea &lt;johanni.brea@epfl.ch&gt;","contact":"Prof. Sahand Jamal Rahi &lt;sahand.rahi@epfl.ch&gt;\r\n\r\nJohanni Brea &lt;johanni.brea@epfl.ch&gt;","is_internal":"False","theme":"","vulgarization":{"id":2,"fr_label":"Public averti","en_label":"Informed public"},"registration":{"id":1,"fr_label":"Sur inscription","en_label":"Registration required"},"keywords":"","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120870/","category":{"id":1,"code":"CONF","fr_label":"Conférences - Séminaires","en_label":"Conferences - Seminars","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/5/?format=json","https://memento.epfl.ch/api/v1/mementos/9/?format=json","https://memento.epfl.ch/api/v1/mementos/111/?format=json"]},{"id":71956,"title":"Topics in Birational Geometry: Seshadri constants, singularities and the Albanese morphism","slug":"topics-in-birational-geometry-seshadri-constants-2","event_url":"https://memento.epfl.ch/event/topics-in-birational-geometry-seshadri-constants-2","visual_url":"https://memento.epfl.ch/image/33264/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33264/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33264/max-size.jpg","lang":"en","start_date":"2026-07-22","end_date":"2026-07-22","start_time":"19:00:00","end_time":null,"description":"<p>Thesis Director: Prof. Z. Patakfalvi,<br>\r\nMathematics doctoral program<br>\r\nThesis Nr. 12192<br>\r\n<br>\r\nTo take part in the public defense, please contact directly the speaker</p>","image_description":"","creation_date":"2026-05-27T15:10:55","last_modification_date":"2026-05-27T15:10:58","link_label":"","link_url":"","canceled":"False","cancel_reason":"","place_and_room":"CM 1 5","url_place_and_room":"https://plan.epfl.ch/?room==CM%201%205","url_online_room":"","spoken_languages":[],"speaker":"<a href=\"mailto:linus.rosler@epfl.ch\"><strong>Linus Erik RÖSLER</strong></a>","organizer":"","contact":"<a href=\"mailto:linus.rosler@epfl.ch\"><strong>Linus Erik RÖSLER</strong></a>","is_internal":"False","theme":"","vulgarization":{"id":1,"fr_label":"Tout public","en_label":"General public"},"registration":{"id":3,"fr_label":"Entrée libre","en_label":"Free"},"keywords":"EDMA","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120872/","category":{"id":12,"code":"SOUTE","fr_label":"Soutenances de thèses","en_label":"Thesis defenses","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/5/?format=json"]},{"id":71960,"title":"A Unified Framework for Modelling Modern Relational Network Data","slug":"a-unified-framework-for-modelling-modern-relatio-2","event_url":"https://memento.epfl.ch/event/a-unified-framework-for-modelling-modern-relatio-2","visual_url":"https://memento.epfl.ch/image/33268/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33268/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33268/max-size.jpg","lang":"en","start_date":"2026-06-30","end_date":"2026-06-30","start_time":"17:30:00","end_time":null,"description":"<p>Thesis Director: Prof. S. C. Olhede,<br>\r\nMathematics doctoral program<br>\r\nThesis Nr. 11276<br>\r\n<br>\r\nTo take part in the public defense, please contact directly the speaker</p>","image_description":"","creation_date":"2026-05-27T15:43:24","last_modification_date":"2026-05-27T15:43:27","link_label":"","link_url":"","canceled":"False","cancel_reason":"","place_and_room":"CM 1 517","url_place_and_room":"https://plan.epfl.ch/?room==CM%201%20517","url_online_room":"https://epfl.zoom.us/j/64047879331?pwd=k15OiafVHBcenbpN3TRDUYtAFmdSBG.1","spoken_languages":[],"speaker":"<a href=\"mailto:charles.dufour@epfl.ch\"><strong>Charles François Paul Pierre DUFOUR</strong></a>","organizer":"","contact":"<a href=\"mailto:charles.dufour@epfl.ch\"><strong>Charles François Paul Pierre DUFOUR</strong></a>","is_internal":"False","theme":"","vulgarization":{"id":1,"fr_label":"Tout public","en_label":"General public"},"registration":{"id":3,"fr_label":"Entrée libre","en_label":"Free"},"keywords":"EDMA","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120880/","category":{"id":12,"code":"SOUTE","fr_label":"Soutenances de thèses","en_label":"Thesis defenses","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/5/?format=json"]}]}